The famous study claiming MDMA is neurotoxic was retracted after researchers discovered they had accidentally used methamphetamine instead of MDMA in their experiment.

The clinical drug ketamine and the street drug PCP (phencyclidine) are the same compound, a fact that is not widely known.

You can improve your ability to focus by deliberately staring at a fixed visual target for a few minutes, which activates the brain's focus circuits for subsequent work.

Non-Sleep Deep Rest (NSDR) protocols can replenish dopamine levels in the brain, restoring mental and physical vigor without disrupting nighttime sleep.

The placebo effect is so powerful that believing you took a higher dose of a cognitive enhancer can improve performance by physically changing the activity levels in relevant brain areas.

A Nobel Prize-winning neuroscientist chews multiple pieces of Nicorette gum daily, believing it may help stave off Parkinson's and Alzheimer's disease.

The feeling of agitation and frustration when you're struggling to learn something is the key neurochemical trigger for neuroplasticity, signaling the brain that it needs to change.

Clinical trials favor psilocybin over LSD primarily for a practical reason: its 3-7 hour duration fits into a clinician's workday, whereas LSD's effects are much longer.

The psychedelic Iboga induces a state where closing your eyes allows you to accurately revisit past life events with the ability to change your behavior within them.

Current clinical trials do not support the effectiveness of microdosing psilocybin, whereas macro-dosing has shown compelling results for treating major depression.